HBM Holdings (HKSE:02142) Total Equity: HK$2,856 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02142 HBM Holdings Ltd HKSE:02142
73 GF Score
Price HK$11.69
GF Value HK$7.03
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is HBM Holdings Total Equity?

HBM Holdings HKSE:02142 -4.65% 73 Total Equity is HK$2,856 Mil as of Dec. 2025. GuruFocus rates HKSE:02142 with a GF Score™ of 73/100 and a GF Value™ of HK$7.03 (Significantly Overvalued). The stock has 4 warning signs investors should review.

HBM Holdings's total equity for the quarter that ended in Dec. 2025 was HK$2,856 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

HBM Holdings Total Equity Historical Data

* Premium members only.

The historical data trend for HBM Holdings's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HBM Holdings Total Equity Chart

HBM Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial 1,738.51 720.16 934.28 964.31 2,856.43

HBM Holdings Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 934.28 959.12 964.31 2,225.72 2,856.43
HKSE:02142
73GF Score
HBM Holdings Ltd HKSE:02142
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HBM Holdings Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

HBM Holdings's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=3892.392-1035.967
=2,856

HBM Holdings's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=3892.392-1035.967
=2,856

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of HK$2,856 Mil mean?
HBM Holdings (HKSE:02142) has a Total Equity of HK$2,856 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for HBM Holdings and its competitors.
Is HBM Holdings' Total Equity too high?
HBM Holdings' current Total Equity is HK$2,856 Mil. Overall, HBM Holdings has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HBM Holdings' Total Equity compare to VRTX and REGN?
HBM Holdings' Total Equity of HK$2,856 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for HBM Holdings and its competitors. HBM Holdings's current Total Equity is HK$2,856 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HBM Holdings stock overvalued right now?
Based on GuruFocus' analysis, HBM Holdings (HKSE:02142) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$7.03, compared to a current price of HK$11.69 — trading 66.3% above its estimated fair value. The current Total Equity is HK$2,856 Mil. HBM Holdings' overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For HBM Holdings (HKSE:02142), the current Total Equity is HK$2,856 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HBM Holdings (HKSE:02142) Overvalued in 2026?

Based on GuruFocus' analysis, HBM Holdings stock appears to be overvalued. The current stock price of HK$11.69 is trading 66.3% above its estimated GF Value™ of HK$7.03. GuruFocus considers HBM Holdings to be Significantly Overvalued.

Key valuation signals for HKSE:02142:

  • Total Equity: HK$2,856 Mil
  • GF Value™: HK$7.03 vs. price of HK$11.69 (66.3% above fair value)
  • GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the HKSE:02142 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HBM Holdings Business Description

Other Exchanges 6XY:Germany
Address No. 388 Fenglin Road, 6th Floor, Tower B, Fenglin International Phase I, Xuhui District, Shanghai, CHN, 200032
HBM Holdings Ltd is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. Its products under development are Batoclimab, for the treatment of a wide spectrum of autoimmune diseases; Tanfanercept, for the treatment of moderate-to-severe dry eye disease (DED); HBM4003; HBM9378, to prevent and treat COVID-19, the pandemic respiratory disease caused by the SARS-CoV-2 virus; HBM7008; and others. Its geographical segments are Mainland China, United States, Europe, and others. The majority of the revenue for the firm is generated from the Europe.
73GF Score

Get the complete analysis for HKSE:02142

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$11.69
Price
HK$7.03
GF Value